Welcome to
Fortuna Herstellung
A Company of the Medios Group
Fortuna Herstellung is one of six GMP-certified compounding facilities for patient-specific therapies within the nationwide Medios Group supply network. As a reliable partner for pharmacies, specialist practices and clinics in the Rhine-Neckar metropolitan region, we provide specialised solutions in oncological preparations and parenteral nutrition.
Committed to Quality - Dedicated to Patients
At Fortuna Herstellung, we compound patient-specific therapies from approved medicinal products in accordance with the highest GMP standards. In our state-of-the-art cleanrooms, our qualified and experienced personnel ensure the highest level of quality, safety and reliability in every preparation. Together with our partners, physicians, pharmacies and clinics, we help ensure the best possible care for seriously ill patients.
As part of the Medios Group, we are part of Germany’s leading supplier of specialty pharmaceuticals and compounder of patient-specific therapies. Through our integration into a strong, nationwide supply network, we can adapt seamlessly to customers‘ needs and ensure quick response times.
Our portfolio includes ready-to-use sterile infusions, primarily for oncology and gastroenterology, as well as parenteral nutrition and investigational medicinal products for mono- and multicentre clinical studies. In addition to our manufacturing license under §13 of the German Medicines Act (AMG), we also hold a wholesale license under §52a AMG.
We offer
- cytostatic preparations
- antibody solutions
- parenteral nutrition
- investigational medicinal products
- other parenteral products
Network that Empowers
Medios strives to be a pioneer in individualized medicine, collaborating with pharmacies, medical specialists, clinics, pharmaceutical companies, and all other stakeholders in the healthcare system, to ensure that people everywhere receive the most innovative pharmacotherapies quickly and safely. We pursue this ambitious goal consistently on multiple levels:
To begin with, through close collaboration between our regional sites and partners across our nationwide supply network, we ensure the highest level of security of patient care in the field of specialized medicinal products. Today, in Germany we are already able to provide patient-specific therapies and specialized medicines within 60 minutes, if required. We aim to expand this capability across Europe in the future.
At the same time, with our leading Specialty Pharma expertise, we’re a strong innovation partner, offering research companies and other collaborators groundbreaking solutions for the efficient implementation of new individualized therapies.
As a Specialty Pharma expert for patient-specific therapies, we have the solution for your individual requirements and provide comprehensive advice on all pharmaceutical, logistics, and billing-related matters.
Expertise meets customer focus
– Every order is a promise
We look forward to getting to know you.
